A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function
Clinical trial NCT00139620 · COMPLETED
Trial details
- NCT number
- NCT00139620
- Sponsor
- OSI Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-22
- Primary completion
- 2007-06-25
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.